COVID-19 Therapeutics for Nonhospitalized Older Adults
- PMID: 39373996
- DOI: 10.1001/jama.2024.16460
COVID-19 Therapeutics for Nonhospitalized Older Adults
Plain language summary
This Viewpoint summarizes the factors contributing to increased risk of severe outcomes and hospitalization associated with COVID-19 among older adults, stresses the importance of assessing COVID-19 risk before infection occurs, calls for all immunocompromised older adults to be considered for COVID-19 treatment, and details 3 recommended COVID-19 therapies.
LinkOut - more resources
Full Text Sources
